SEER Data: It Can Be Thought Provoking, But Where Do We Go From Here? Nicholas J. Petrelli Editorial 24 May 2007 Pages: 2173 - 2174
Resecting Lymph Nodes in Colon Cancer: More than a Staging Operation? Steven L. ChenAnton J. Bilchik EditorialNotes 25 May 2007 Pages: 2175 - 2176
Validating a Predictive Model for Presence of Additional Disease in the Non–Sentinel Lymph Nodes of a Woman with Sentinel Node Positive Breast Cancer Kimberly J. Van ZeeMichael W. Kattan Editorial 17 May 2007 Pages: 2177 - 2178
Sentinel Lymph Node Biopsy for DCIS: Are We Approaching Consensus? Hiram S. Cody III Editorial 30 January 2007 Pages: 2179 - 2181
Lymphatic Mapping and Sentinel Lymph Node Biopsy for Locally Recurrent Breast Cancer: New Clues to Understanding the Biology of Chest Wall Relapse Lisa A. Newman Editorial 20 May 2007 Pages: 2182 - 2184
Consensus Statement on Mandatory Registration of Clinical Trials Events 16 May 2007 Pages: 2185 - 2186
Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data Jennifer GnerlichDonna B. JeffeJulie A. Margenthaler Breast Oncology 24 May 2007 Pages: 2187 - 2194
Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non–Sentinel Node Involvement After Positive Sentinel Node Biopsy Séverine AlranYann De RyckeBrigitte Sigal-Zafrani Breast 09 February 2007 Pages: 2195 - 2201
Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS? Thomas B. JulianStephanie R. LandNorman Wolmark Original Research 30 May 2007 Pages: 2202 - 2208
Reoperative Sentinel Lymph Node Biopsy: A New Frontier in the Management of Ipsilateral Breast Tumor Recurrence Elisa Rush PortCarlos A. Garcia-EtienneHiram S. Cody III OriginalPaper 01 February 2007 Pages: 2209 - 2214
Preoperative Lymphoscintigraphy Predicts the Successful Identification but Is Not Necessary in Sentinel Lymph Nodes Biopsy in Breast Cancer Lei WangJin-ming YuPeng Chen Breast Oncology 24 May 2007 Pages: 2215 - 2220
Size of Sentinel Node Tumor Deposits and Extent of Axillary Lymph Node Involvement: Which Breast Cancer Patients May Benefit From Less Aggressive Axillary Dissections? Elena SamoilovaJoseph T. DavisLuis M. Samayoa Breast Oncology 05 June 2007 Pages: 2221 - 2227
Superiority of Sonographic Hematoma Guided Resection of Mammogram Only Visible Breast Cancer: Wire Localization Should be an Exception—Not the Rule Rakhshanda Layeequr RahmanSybil CrawfordRobert Quinlan Breast Oncology 19 May 2007 Pages: 2228 - 2232
Tattooing Breast Cancers Treated with Neoadjuvant Chemotherapy Marie-Christine MathieuLaurence Bonhomme-FaivreJean-Paul Travagli OriginalPaper 16 May 2007 Pages: 2233 - 2238
Prognostic Factors in Primary Gastric Lymphoma Heriberto Medina-FrancoSantos Soto GermesCarmen Lome Maldonado OriginalPaper 02 June 2007 Pages: 2239 - 2245
Single Nucleotide Polymorphisms in the Promoter Region of the E-cadherin Gene in Gastric Cancer: Case-Control Study in a Young Mexican Population Heriberto Medina-FrancoAntonio Ramos-De la MedinaJose Luis Medina-Franco OriginalPaper 05 June 2007 Pages: 2246 - 2249
Heme Oxygenase-1 Gene Promoter Polymorphism is Associated with Risk of Gastric Adenocarcinoma and Lymphovascular Tumor Invasion Su-Shun LoShu-Chun LinWin-Yiu Lui OriginalPaper 23 May 2007 Pages: 2250 - 2256
Location of Rectal Cancer Within the Circumference of the Rectum Does Not Influence Lymph Node Status Alexis UlrichKatrin HimmerJürgen Weitz OriginalPaper 23 May 2007 Pages: 2257 - 2262
Surgical Management and Outcome in Primary Adenocarcinoma of the Small Bowel Shefali AgrawalEdward C. McCarronAshwani Rajput Gastrointestinal Oncology 05 June 2007 Pages: 2263 - 2269
Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy—A Journey to Becoming a Nationally Funded Peritonectomy Center Tristan D. YanMatthew LinksDavid L. Morris Gastrointestinal Oncology 27 April 2007 Pages: 2270 - 2280
Failure Analysis of Recurrent Disease Following Complete Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer Lana BijelicTristan D. YanPaul H. Sugarbaker Gastrointestinal Oncology 15 May 2007 Pages: 2281 - 2288
Critical Analysis of Treatment Failure After Complete Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Dissemination From Appendiceal Mucinous Neoplasms Tristan D. YanLana BijelicPaul H. Sugarbaker Gastrointestinal Oncology 01 June 2007 Pages: 2289 - 2299
Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Dario BarattiShigeki KusamuraMarcello Deraco Thoracic Oncology 18 May 2007 Pages: 2300 - 2308
Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis Sherry J. LimJanice N. CormierKelly K. Hunt Bone and Soft Tissue Sarcomas 31 May 2007 Pages: 2309 - 2318
Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors Dongil ChoiHyo K. LimCheol Keun Park OriginalPaper 24 May 2007 Pages: 2319 - 2329
Significance of Common Hepatic Artery Lymph Node Metastases During Pancreaticoduodenectomy for Pancreatic Head Adenocarcinoma Fernando CorderaCletus A. ArcieroJohn P. Hoffman OriginalPaper 10 May 2007 Pages: 2330 - 2336
Analysis of Prognostic Factors Affecting Survival After Initial Recurrence and Treatment Efficacy for Recurrence in Patients Undergoing Potentially Curative Hepatectomy for Hepatocellular Carcinoma Kazuaki ShimadaYoshihiro SakamotoKenichi Takayasu Hepatic and Pancreatic Tumors 15 May 2007 Pages: 2337 - 2347
The Ability of Existing Questionnaires to Measure Symptom Change After Paracentesis for Symptomatic Ascites Alexandra M. EassonAndrea BezjakJim G. Wright OriginalPaper 16 May 2007 Pages: 2348 - 2357
Isolated Adrenal Mass in Patients with a History of Cancer: Remember Pheochromocytoma Joel T. AdlerEberhard MackHerbert Chen Endocrine Tumors 16 May 2007 Pages: 2358 - 2362
The Negative Sestamibi Scan: Is a Minimally Invasive Parathyroidectomy Still Possible? Alysandra LalHerbert Chen Endocrine Tumors 24 May 2007 Pages: 2363 - 2366
A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma Kimberly A. VarkerJennifer E. BiberWilliam E. Carson III Melanoma 30 May 2007 Pages: 2367 - 2376
Reliability of Lymphatic Mapping After Wide Local Excision of Cutaneous Melanoma Stephan AriyanPia Ali-SalaamCarolyn Truini Melanomas 01 June 2007 Pages: 2377 - 2383
Comparing Surgical Outcomes in Obese Women Undergoing Laparotomy, Laparoscopy, or Laparotomy With Panniculectomy for the Staging of Uterine Malignancy Eric L. EisenhauerKelly A. WypychNadeem R. Abu-Rustum Head and Neck Oncology 24 May 2007 Pages: 2384 - 2391
Laparoscopic Sentinel Node Biopsy in Cervical Cancer Using a Combined Detection: 5–Years Experience Charles CoutantOlivier MorelEmmanuel Barranger Gynecologic Oncology 16 May 2007 Pages: 2392 - 2399
Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung Cancer Amgad El-SherifHiran C. FernandoRodney J. Landreneau Thoracic Oncology 16 May 2007 Pages: 2400 - 2405
Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer Samuel B. KeeleyArjun PennathurJames Luketich Gastrointestinal Oncology 30 May 2007 Pages: 2406 - 2410
Use of an Artificial Lymphatic System During Carboplatin Infusion to Improve Canine Osteosarcoma Blood Flow and Clinical Response Gene R. DiRestaSean W. AikenJohn H. Healey Laboratory Research 15 May 2007 Pages: 2411 - 2421
Validation of a Breast Cancer Nomogram for Predicting Nonsentinel Lymph Node Metastases after a Positive Sentinel Node Biopsy L. A. LambertG. D. AyersF. Meric-Bernstam Breast Oncology 19 May 2007 Pages: 2422 - 2423
